Related Experiment Video
Updated: Jul 6, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
The role of ATF-2 in oncogenesis
Spiros A Vlahopoulos1, Stella Logotheti, Dimitris Mikas
1Unit of Biomedical Applications, Institute of Biological Research and Biotechnology, National Hellenic Research Foundation, Athens, Greece.
Abstract:
Activating Transcription Factor-2 is a sequence-specific DNA-binding protein that belongs to the bZIP family of proteins and plays diverse roles in the mammalian cells. In response to stress stimuli, it activates a variety of gene targets including cyclin A, cyclin D and c-jun, which are involved in oncogenesis in various tissue types. ATF-2 expression has been correlated with maintenance of a cancer cell phenotype. However, other studies demonstrate an antiproliferative or apoptotic role for ATF-2. In this review, we summarize the signaling pathways that activate ATF-2, as well as its downstream targets. We examine the role of ATF-2 in carcinogenesis with respect to other bZIP proteins, using data from studies in human cancer cell lines, human tumours and mouse models, and we propose a potential model for its function in carcinogenesis, as well as a theoretical basis for its utility in anticancer drug design.
Insights
Activating Transcription Factor-2 (ATF-2) has dual roles in cancer, potentially promoting or inhibiting tumor growth. This review explores ATF-2
Area of Science:
- Molecular Biology
- Oncology
- Cellular Signaling
Background:
- Activating Transcription Factor-2 (ATF-2) is a bZIP transcription factor with varied functions in mammalian cells.
- ATF-2 regulates genes involved in cell proliferation, such as cyclin A, cyclin D, and c-jun, which are implicated in oncogenesis.
- The role of ATF-2 in cancer is complex, with studies suggesting both pro-tumorigenic and anti-tumorigenic effects.
Purpose of the Study:
- To review signaling pathways that activate ATF-2.
- To summarize ATF-2's downstream targets and their role in oncogenesis.
- To examine ATF-2's function in carcinogenesis and its potential as a target for anticancer drug design.
Main Methods:
- Literature review of signaling pathways activating ATF-2.
- Analysis of ATF-2 downstream targets, including cyclins and c-jun.
- Examination of data from human cancer cell lines, tumors, and mouse models.
Main Results:
- ATF-2 activation pathways and downstream targets involved in oncogenesis were identified.
- Evidence suggests ATF-2 expression correlates with cancer cell phenotype maintenance.
- Contrasting evidence indicates ATF-2 may also possess antiproliferative or apoptotic functions.
Conclusions:
- ATF-2 plays a multifaceted role in carcinogenesis, influenced by cellular context and signaling.
- A functional model for ATF-2 in carcinogenesis is proposed.
- ATF-2 presents a potential target for novel anticancer therapeutic strategies.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
DNA Damage can Stall the Cell Cycle

